57 results
6-K
EX-99.2
THTX
Theratechnologies Inc.
15 Apr 24
Notice of Annual Meeting of Shareholders
9:31am
of the Corporation; or
Retaining the services of a third party specialized in the recruitment of directors.
Prior to retaining any individual to act as director … .
The Committee shall proceed as follows for the recruitment of candidates:
when determined by the Committee and the Board of Directors that Board
6-K
EX-99.2
THTX
Theratechnologies Inc.
10 Apr 24
Interim Consolidated Financial Statements
8:30am
these with any potential partner we may find to optimize the design, if deemed relevant. The Corporation expects that the recruitment and dosing of the first
6-K
EX-99.1
THTX
Theratechnologies Inc.
22 Mar 24
Theratechnologies Announces Update on its Preclinical Oncology Research Program
4:27pm
1 trial of sudocetaxel zendusortide, in which the first patient has already received treatment at a higher dose. Recruitment has been ramped up
6-K
EX-99.1
THTX
Theratechnologies Inc.
21 Mar 24
Current report (foreign)
12:40pm
Medical Review Committee approved initiation of recruitment of next cohort of patients, in alignment with dose optimization protocol
First patient out
SUPPL
p2ugl1wlcowkw
26 Oct 23
Supplemental materials (foreign)
9:13pm
SUPPL
7lygib avi
25 Oct 23
Supplemental materials (foreign)
6:56pm
6-K
EX-99.1
byybph6czo 4u
12 Jul 23
Theratechnologies Reports Second Quarter 2023
8:00am
6-K
EX-99.1
masqrlgir nh7nyxbv
2 Jun 23
Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
1:02pm
6-K
EX-99.2
kcvy5ybm9uyd4c0
13 Apr 23
Notice of Annual Meeting of Shareholders
8:01am
6-K
EX-99.2
go7f 5qjdso
14 Apr 22
Notice of Annual Meeting of Shareholders
4:23pm
6-K
EX-99.2
5zxh3bj57dh0tjx
13 Apr 22
Interim Consolidated Financial Statements
7:45am
6-K
EX-99.1
a08jby
13 Apr 22
Theratechnologies Reports Financial Results
7:30am
40-F
EX-99.1
t3fod
24 Feb 22
Annual report (Canada)
8:02am
40-F
EX-99.2
i1vbgcixjmofkk
24 Feb 22
Annual report (Canada)
8:02am
SUPPL
5nz166l2kmp5s uk7
26 Jul 21
Supplemental materials (foreign)
12:00am
6-K
EX-99.1
7bdul s6bu
15 Jul 21
Theratechnologies Reports Financial Results
7:05am
6-K
EX-99.1
ydrgt
14 May 21
Announcements In Conjunction with Theratechnologies Annual Meeting
12:00am
6-K
EX-99.2
tthfpe
16 Apr 21
Notice of Annual Meeting of Shareholders
4:00pm